TiRigenera is a brand of ARICOL SA , a Swiss company based in Lugano, that operates in the biotechnology sector for regenerative medicine We distribute the innovative and unique RIGENERA (tm) medical device in the Swiss territory. The protocol based on RIGENERA allows the autologous method of micro-tissue grafting in regenerative medicine. RIGENERA(tm) is a medical device, CE ans FDA certified, capable of transforming, through a single mechanical action, a graft, whether it is bone, cartilage, muscle or tissue, in 70-80 microns micrografts while maintaining a 70/80% cell vitality. This mechanical action is able to isolate from the original graft the stromal vascular fraction rich in active and perennial mesenchymal cells capable of accelerating the natural regenerative tissue process. TiRigenera was founded to distribute the medical device, spread the methodology and develop its evolution for applications in Aesthetic Medicine and in particular for the treatment of Androgenetic Alopecia, regeneration and skin rejuvenation and scaling of stretch marks. The dissemination of the methodology and its evolution is guaranteed by an external Medical Plastic Surgeons Faculty located in Swiss. www.tirigenera.ch For information: info@tirigenera.ch